does medicare cover semaglutide for diabetes Ozempic in Washington State 2026? A New Use for Wegovy

Tirzepatide cardiovascular outcome trials are ongoing

In one 52-week trial, semaglutide produced an 8.8% weight loss along with significantly lower total hip and lumbar spine BMD and higher bone resorption markers compared with placebo, and a large cardiovascular outcomes trial with more than 17,000 participants reported nearly a 5-fold higher incidence of hip and pelvic fractures in adults 75 years and older using semaglutide versus placebo

Combined with potential fluid losses from gastrointestinal side effects, dehydration and electrolyte imbalances can occur

It also aids in pain relief and healing digestive disorders

Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E